Specialized Hyaluronate Compositions for Niche Environments

Publication ID: 24-11857682_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Hyaluronate Compositions for Niche Environments,” Published Technical Disclosure No. 24-11857682_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857682_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,682.

Summary of the Inventive Concept

A family of hyaluronate compositions tailored for specific, demanding environments, ensuring optimal performance and safety in high-altitude, disaster relief, high-security, extreme weather, and telemedicine-assisted dermal filling applications.

Background and Problem Solved

The original patent's hyaluronate compositions, while effective for general dermal filling, may not provide optimal results in specialized environments. This inventive concept addresses the limitations of the original patent by adapting the compositions for unique operational conditions, ensuring superior performance, safety, and efficacy.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of hyaluronate compositions, each optimized for a specific niche environment. For high-altitude environments, the composition features minimized soluble fractions and maximized crosslinking to ensure stability and effectiveness at elevated pressures. In disaster relief situations, the composition includes an antimicrobial agent to prevent infection. For high-security facilities, the composition incorporates a tracking agent to monitor movement. In extreme weather conditions, the composition is designed to maintain its viscoelastic properties across a broad temperature range, and may be paired with a heating or cooling device. Finally, the composition for telemedicine-assisted dermal filling is adapted for remote injection, featuring a communication module for transmitting injection data to a remote monitoring station.

Novelty and Inventive Step

The new claims introduce novel adaptations of the original hyaluronate compositions, specifically tailored for unique operational environments. The inventive step lies in the combination of specialized composition designs, additives, and operational features that address the specific challenges of each niche environment.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include compositions adapted for other specialized environments, such as space exploration, military operations, or search and rescue missions. Variations could also include different types of hyaluronic acid or crosslinking agents, as well as alternative additives or operational features.

Potential Commercial Applications and Market

The specialized hyaluronate compositions have significant commercial potential in various industries, including cosmetics, pharmaceuticals, and medical devices. Target markets include high-altitude regions, disaster relief organizations, high-security facilities, and telemedicine providers.

CPC Classifications

SectionClassGroup
A A61 A61K9/1652
A A61 A61K8/735
A A61 A61K9/0019
A A61 A61K9/06
A A61 A61K9/1658
A A61 A61K31/167
A A61 A61K47/42
A A61 A61Q19/08

Field of Art

Biomaterials and pharmaceutical compositions, specifically hyaluronic acid-based dermal fillers and tissue engineering, requiring advanced knowledge of polymer chemistry, medical device design, and biotechnology

Person of Ordinary Skill (PHOSITA) Profile

A professional with a PhD or equivalent experience in biomaterials engineering, with expertise in polymer modification, crosslinking techniques, and medical device formulation, familiar with hyaluronic acid's properties and applications in aesthetic and reconstructive medicine

Obviousness Rationale

A PHOSITA would recognize that the disclosed variations represent predictable extensions of the source patent's core hyaluronate composition technology, applying standard engineering problem-solving techniques to adapt the base formulation for specialized environmental conditions by introducing minor compositional and functional modifications that do not require inventive complexity.

Obvious Combinations & Variations

Source Patent Element
Crosslinked hyaluronic acid composition with specific NaCl concentration and particle size
PTD Variation
Adapting composition for high-altitude environments by modifying crosslinking ratio and particle size
Obviousness Reasoning
Adjusting crosslinking parameters to maintain stability under different pressure conditions is a routine optimization for a PHOSITA familiar with polymer behavior
Source Patent Element
Method of preparing hyaluronate solution with local anesthetic
PTD Variation
Adding antimicrobial agents to the composition for disaster relief applications
Obviousness Reasoning
Introducing additional functional agents into a known base formulation represents a predictable variation using standard pharmaceutical compounding techniques
Source Patent Element
Hyaluronate composition with specific particle size and crosslinking characteristics
PTD Variation
Incorporating tracking agents and communication modules for monitoring and remote data transmission
Obviousness Reasoning
Integrating standard tracking and communication technologies into medical compositions is an obvious design choice for enhanced functionality and monitoring
Source Patent Element
Uncrosslinked hyaluronic acid preparation method with specific salt concentration
PTD Variation
Developing compositions with temperature-adaptive properties for extreme weather conditions
Obviousness Reasoning
Modifying polymer formulations to maintain performance across temperature ranges is a standard engineering approach in biomaterials design
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857682, a Person Having Ordinary Skill In The Art would find the variations disclosed herein to be obvious extensions of the prior art, representing predictable modifications to a known hyaluronate composition technology that do not rise to the level of non-obvious innovation, thus rendering potential claims to such variations unpatentable under 35 U.S.C. ยง 103.

Original Patent Information

Patent NumberUS 11,857,682
TitleHyaluronate compositions and soft tissue fillers
Assignee(s)AMC